Emergent BioSolutions Inc.: CFO to step down, interim CFO appointed

What happened

• The filing says Emergent BioSolutions Inc announced that Richard Lindahl, the company’s chief financial officer, will step down from his role as principal financial and accounting officer effective Dec 31, 2026 and will continue as an advisor until his retirement on Mar 31, 2027.
• The filing says the company appointed Frank Vargo, vice president, treasurer, to serve as interim chief financial officer and principal financial and accounting officer beginning on Jan 1, 2027. The filing says Mr. Lindahl will assist with the transition, including preparation and filing of the company’s Annual Report on Form 10-K for the year ending Dec 31, 2026.

Key details

• Mr. Vargo, age 43, joined the company in Dec 2019 and was named vice president, treasurer in Nov 2025.
• The board approved interim additional pay of $3,850 per pay period for Mr. Vargo, in addition to his current base salary of $328,000, commencing Jan 1, 2027.
• The filing says Mr. Lindahl’s compensation as an advisor will be materially consistent with his current compensation.

Why it may matter

• This report was made under Item 5.02 (Departure of directors or certain officers), which covers changes in the company’s executive officers and principal financial and accounting officer.
• The filing includes transition arrangements and interim compensation for the interim CFO and notes that Mr. Lindahl will help with the company’s Form 10-K for the year ending Dec 31, 2026. The filing does not show why the insider traded or why the company acted.